UBS Downgrades Coca-Cola Femsa to Neutral, Raises Price Target to $80
UBS analyst Rodrigo Alcantara downgrades Coca-Cola Femsa (NYSE:KOF) from Buy to Neutral and raises the price target from $76 to $80.
Williams Trading Downgrades VF to Sell, Announces $25 Price Target
Williams Trading analyst Sam Poser downgrades VF (NYSE:VFC) from Hold to Sell and announces $25 price target.
MoffettNathanson Downgrades DXC Technology to Underperform, Lowers Price Target to $28
MoffettNathanson analyst Lisa Ellis downgrades DXC Technology (NYSE:DXC) from Market Perform to Underperform and lowers the price target from $32 to $28.
Jefferies Downgrades Inotiv to Hold, Lowers Price Target to $8
Jefferies analyst David Windley downgrades Inotiv (NASDAQ:NOTV) from Buy to Hold and lowers the price target from $10 to $8.
BofA Downgrades Levi Strauss On Cautious North America Outlook
BofA Securities analyst downgraded Levi Strauss & Co (NYSE:LEVI) from Buy to Neutral and lowered the price target from $19 to $17.…
Evercore ISI Group Downgrades TE Connectivity to In-Line, Announces $130 Price Target
Evercore ISI Group analyst Amit Daryanani downgrades TE Connectivity (NYSE:TEL) from Outperform to In-Line and announces $130 price target.
JMP Securities Downgrades Intellia Therapeutics to Market Perform
JMP Securities analyst Silvan Tuerkcan downgrades Intellia Therapeutics (NASDAQ:NTLA) from Market Outperform to Market Perform.
Why Chegg Shares Are Dipping Today
Chegg, Inc. (NYSE: CHGG) shares are trading lower following a downgrade from Needham.
Raymond James Upgrades Natera & Myriad Genetics, While Downgrading This Stock
Raymond James upgraded Natera Inc (NASDAQ:NTRA) to Outperform from Market Perform and a price target of $58 on a catalyst-rich setup for 2023…
B of A Securities Downgrades Graphite Bio to Neutral, Lowers Price Target to $3
B of A Securities analyst Geoff Meacham downgrades Graphite Bio (NASDAQ:GRPH) from Buy to Neutral and lowers the price target from $7 to $3.